annual FCF:
-$176.66M-$153.72M(-670.21%)Summary
- As of today (September 17, 2025), CDTX annual free cash flow is -$176.66 million, with the most recent change of -$153.72 million (-670.21%) on December 31, 2024.
- During the last 3 years, CDTX annual FCF has fallen by -$151.39 million (-599.01%).
- CDTX annual FCF is now -16757.06% below its all-time high of -$1.05 million, reached on December 31, 2013.
Performance
CDTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$40.96M-$19.01M(-86.61%)Summary
- As of today (September 17, 2025), CDTX quarterly free cash flow is -$40.96 million, with the most recent change of -$19.01 million (-86.61%) on June 30, 2025.
- Over the past year, CDTX quarterly FCF has increased by +$62.82 million (+60.53%).
- CDTX quarterly FCF is now -246.48% below its all-time high of $27.96 million, reached on September 30, 2022.
Performance
CDTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$129.13M+$62.82M(+32.73%)Summary
- As of today (September 17, 2025), CDTX TTM free cash flow is -$129.13 million, with the most recent change of +$62.82 million (+32.73%) on June 30, 2025.
- Over the past year, CDTX TTM FCF has dropped by -$4.02 million (-3.21%).
- CDTX TTM FCF is now -31317.52% below its all-time high of -$411.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
CDTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -670.2% | +60.5% | -3.2% |
| 3 y3 years | -599.0% | -245.6% | -106.8% |
| 5 y5 years | -518.4% | -189.1% | -362.6% |
CDTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -670.2% | at low | -246.5% | +60.5% | -9652.7% | +32.7% |
| 5 y | 5-year | -670.2% | at low | -246.5% | +60.5% | -9652.7% | +32.7% |
| alltime | all time | <-9999.0% | at low | -246.5% | +60.5% | <-9999.0% | +32.7% |
CDTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$40.96M(+86.6%) | -$129.13M(-32.7%) |
| Mar 2025 | - | -$21.95M(-25.4%) | -$191.94M(+8.7%) |
| Dec 2024 | -$176.66M(+670.2%) | -$29.41M(-20.1%) | -$176.66M(+10.3%) |
| Sep 2024 | - | -$36.80M(-64.5%) | -$160.15M(+28.0%) |
| Jun 2024 | - | -$103.78M(+1456.6%) | -$125.11M(+572.2%) |
| Mar 2024 | - | -$6.67M(-48.3%) | -$18.61M(-18.9%) |
| Dec 2023 | -$22.94M(-19.8%) | -$12.90M(+633.0%) | -$22.94M(-26.1%) |
| Sep 2023 | - | -$1.76M(-164.8%) | -$31.05M(+2245.0%) |
| Jun 2023 | - | $2.71M(-124.7%) | -$1.32M(-91.7%) |
| Mar 2023 | - | -$10.99M(-47.7%) | -$15.89M(-44.4%) |
| Dec 2022 | -$28.59M(+13.1%) | -$21.01M(-175.1%) | -$28.59M(+27.1%) |
| Sep 2022 | - | $27.96M(-335.9%) | -$22.49M(-64.0%) |
| Jun 2022 | - | -$11.85M(-50.0%) | -$62.44M(+32.4%) |
| Mar 2022 | - | -$23.69M(+58.9%) | -$47.16M(+86.6%) |
| Dec 2021 | -$25.27M(-53.7%) | -$14.91M(+24.4%) | -$25.27M(+17.6%) |
| Sep 2021 | - | -$11.98M(-450.1%) | -$21.49M(-9.1%) |
| Jun 2021 | - | $3.42M(-289.6%) | -$23.65M(-42.7%) |
| Mar 2021 | - | -$1.80M(-83.8%) | -$41.24M(-24.5%) |
| Dec 2020 | -$54.60M(+91.1%) | -$11.13M(-21.3%) | -$54.60M(-6.9%) |
| Sep 2020 | - | -$14.14M(-0.2%) | -$58.67M(+110.2%) |
| Jun 2020 | - | -$14.17M(-6.6%) | -$27.91M(+5.0%) |
| Mar 2020 | - | -$15.16M(-0.2%) | -$26.58M(-7.0%) |
| Dec 2019 | -$28.57M | -$15.20M(-191.4%) | -$28.57M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $16.62M(-229.5%) | -$27.08M(-52.1%) |
| Jun 2019 | - | -$12.83M(-25.2%) | -$56.56M(-4.6%) |
| Mar 2019 | - | -$17.16M(+25.2%) | -$59.28M(+4.2%) |
| Dec 2018 | -$56.88M(+13.3%) | -$13.71M(+6.5%) | -$56.88M(+7.7%) |
| Sep 2018 | - | -$12.87M(-17.3%) | -$52.81M(-1.8%) |
| Jun 2018 | - | -$15.56M(+5.4%) | -$53.80M(+6.9%) |
| Mar 2018 | - | -$14.75M(+53.2%) | -$50.33M(+0.2%) |
| Dec 2017 | -$50.22M(+25.0%) | -$9.63M(-30.5%) | -$50.22M(-4.2%) |
| Sep 2017 | - | -$13.86M(+14.6%) | -$52.42M(+13.2%) |
| Jun 2017 | - | -$12.09M(-17.4%) | -$46.32M(+5.6%) |
| Mar 2017 | - | -$14.63M(+23.6%) | -$43.87M(+9.2%) |
| Dec 2016 | -$40.17M(+48.1%) | -$11.84M(+52.6%) | -$40.17M(+13.1%) |
| Sep 2016 | - | -$7.76M(-19.5%) | -$35.53M(-0.3%) |
| Jun 2016 | - | -$9.63M(-11.9%) | -$35.63M(+11.4%) |
| Mar 2016 | - | -$10.94M(+51.9%) | -$31.99M(+17.9%) |
| Dec 2015 | -$27.13M(+211.8%) | -$7.20M(-8.3%) | -$27.13M(+16.7%) |
| Sep 2015 | - | -$7.85M(+31.1%) | -$23.25M(+23.8%) |
| Jun 2015 | - | -$5.99M(-1.5%) | -$18.78M(+30.7%) |
| Mar 2015 | - | -$6.08M(+83.3%) | -$14.37M(+65.2%) |
| Dec 2014 | -$8.70M(+730.2%) | -$3.32M(-2.2%) | -$8.70M(+61.6%) |
| Sep 2014 | - | -$3.39M(+114.5%) | -$5.38M(+170.2%) |
| Jun 2014 | - | -$1.58M(+284.7%) | -$1.99M(+384.7%) |
| Mar 2014 | - | -$411.00K | -$411.00K |
| Dec 2013 | -$1.05M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual FCF year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Cidara Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM FCF year-on-year change?
What is Cidara Therapeutics, Inc. annual free cash flow?
The current annual FCF of CDTX is -$176.66M
What is the all time high annual FCF for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual free cash flow is -$1.05M
What is Cidara Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, CDTX annual free cash flow has changed by -$153.72M (-670.21%)
What is Cidara Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of CDTX is -$40.96M
What is the all time high quarterly FCF for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly free cash flow is $27.96M
What is Cidara Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, CDTX quarterly free cash flow has changed by +$62.82M (+60.53%)
What is Cidara Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of CDTX is -$129.13M
What is the all time high TTM FCF for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM free cash flow is -$411.00K
What is Cidara Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, CDTX TTM free cash flow has changed by -$4.02M (-3.21%)